13F HOLDINGS REPORT
Vantage Consulting Group Inc
Quarter ended Q1 2025 · Filed May 9, 2025 · Accession 0001843547-25-000007
Total Value
$5.0M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cibus, Inc. | CBUS | 1,143,949 | $2.1M | 42.58% |
| 2 | Babcock & Wilcox Enterprises Inc. | BW-PA | 2,416,200 | $1.6M | 32.34% |
| 3 | ADC Therapeutics SA | ADCT | 850,737 | $1.2M | 23.88% |
| 4 | Fibrogen, Inc | 31572Q808 | 195,707 | $60,650 | 1.21% |